GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study HR Whittaker, C Gulea, A Koteci, C Kallis, AD Morgan, C Iwundu, ... bmj 375, 2021 | 48 | 2021 |
Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison C Gulea, R Zakeri, V Alderman, A Morgan, J Ross, JK Quint Respiratory research 22, 1-14, 2021 | 43 | 2021 |
Model-based comorbidity clusters in patients with heart failure: association with clinical outcomes and healthcare utilization C Gulea, R Zakeri, JK Quint BMC medicine 19, 1-13, 2021 | 24 | 2021 |
Assessing social networks in patients with psychotic disorders: a systematic review of instruments J Siette, C Gulea, S Priebe PloS one 10 (12), e0145250, 2015 | 21 | 2015 |
Utility value estimates in cardiovascular disease and the effect of changing elicitation methods: a systematic literature review MB Betts, P Rane, E Bergrath, M Chitnis, MK Bhutani, C Gulea, Y Qian, ... Health and quality of life outcomes 18, 1-12, 2020 | 17 | 2020 |
Impact of chronic obstructive pulmonary disease on readmission after hospitalization for acute heart failure: A nationally representative US cohort study C Gulea, R Zakeri, JK Quint International journal of cardiology 290, 113-118, 2019 | 13 | 2019 |
Differences in outcomes between heart failure phenotypes in patients with coexistent chronic obstructive pulmonary disease: a cohort study C Gulea, R Zakeri, JK Quint Annals of the American Thoracic Society 19 (6), 971-980, 2022 | 8 | 2022 |
Post-acute COVID-19 sequelae in cases managed in the community or hospital in the UK: a population based study HR Whittaker, C Gulea, A Koteci, C Kallis, AD Morgan, C Iwundu, ... medRxiv, 2021.04. 09.21255199, 2021 | 7 | 2021 |
Clinical and methodological considerations when interpreting meta-analyses of beta-blocker use in patients with chronic obstructive pulmonary disease C Gulea, JK Quint, R Zakeri European Heart Journal 42 (34), 3407-3408, 2021 | 5 | 2021 |
Impact of COPD and asthma on in-hospital mortality and management of patients with heart failure in England and Wales: an observational analysis C Gulea, R Zakeri, C Kallis, JK Quint BMJ open 12 (6), e059122, 2022 | 4 | 2022 |
Effect of beta-blocker therapy on clinical outcomes, safety, health-related quality of life and functional capacity in patients with chronic obstructive pulmonary disease (COPD … C Gulea, R Zakeri, JK Quint BMJ open 8 (11), e024736, 2018 | 3 | 2018 |
Prognostic differences between heart failure with preserved versus reduced ejection fraction in people with COPD C Gulea, R Zakeri, JK Quint European Respiratory Journal 58 (suppl 65), 2021 | | 2021 |
Post-acute COVID-19 sequelae in cases managed in the community or hospital in the UK: a population based study (preprint) HR Whittaker, C Gulea, A Koteci, C Kallis, AD Morgan, C Iwundu, ... | | 2021 |
Evaluating the role of COPD in patients with heart failure using multiple electronic health data sources CS Gulea Imperial College London, 2021 | | 2021 |
Transatlantic differences in healthcare systems captured by large administrative databases: Assessing the burden of COPD in patients admitted for heart failure C Gulea, R Zakeri, JK Quint PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 52-52, 2020 | | 2020 |
Utility value estimates in cardiovascular disease and the effect of changing elicitation methods: a systematic literature MB Betts, P Rane, E Bergrath, M Chitnis, MK Bhutani, C Gulea, Y Qian, ... | | 2020 |
Reply to letter to the editor by Dr. Jolobe C Gulea, R Zakeri, JK Quint International Journal of Cardiology 292, 161, 2019 | | 2019 |
Missed opportunity to manage COPD in patients hospitalised for heart failure C Gulea, R Zakeri, JK Quint European Respiratory Journal 54 (suppl 63), 2019 | | 2019 |
81 Why do patients with concomitant HF and COPD return to hospital? risk factors and reasons for short-term readmission C Gulea, R Zakeri, JK Quint Heart 105 (Suppl 6), A68-A69, 2019 | | 2019 |
P67 Temporal trends in heart failure incidence among patients with COPD and all-cause mortality of patients with comorbid COPD and heart failure in UK primary care, 2006–2016 EL Axson, V Sundaram, A Gayle, C Gulea, CI Bloom, R Zakeri, A Bottle, ... Thorax 73 (Suppl 4), A137-A138, 2018 | | 2018 |